Hanlim Pharm Co., Ltd.

Form 483FOIA Uncovered

Yonginsi Ceoin-gu, -, Korea (the Republic of)FEI 3004886113Issued May 31, 2022

View FDA's Record for This Firm

Source: FDA inspection record. Confirmed against FDA's published inspection data for this establishment and inspection date. FDA has published the inspection and what it cited, but not the form itself, which usually takes six to twelve months. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 3004886113.

Observations2

Issue DateMay 31, 2022

Status2 Related Warning Letters

Related Inspections6

Establishment Details

Firm: Hanlim Pharm Co., Ltd.
Location: Yonginsi Ceoin-gu, -, Korea (the Republic of)
FEI Number: 3004886113
Product Type: Drugs
Issue Date: May 31, 2022
Country: Korea (the Republic of)

Inspection History, 2014 to 2026

NAI1

VAI3

OAI2

NAI means No Action Indicated. VAI means Voluntary Action Indicated. OAI means Official Action Indicated.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

Hanlim Pharm Co., Ltd. FDA Form 483, Yonginsi Ceoin-gu, May 31, 2022